Loading
This study tests a PARP inhibitor; the registry reports that it is recruiting.
The registry lists NCT05473624 as recruiting, last updated 2025-04-15. Enrolment is 153 planned participants, an estimate. Interventions: HRS-1167. Primary measures include Dose-limiting toxicity (DLT) of HRS-1167; Maximum tolerated dose (MTD) of HRS-1167. No results are posted in the registry; this does not exclude separate publications.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/